LFWD – lifeward ltd. - ordinary shares (US:NASDAQ)

News

Lifeward Successfully Closes on Strategic Partnership with Oramed
Lifeward (LFWD) had its price target raised by HC Wainwright from $4.50 to $10.00. They now have a "buy" rating on the stock.
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com